The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Weston, Colin James
    Assistant Director Commercial Development born in April 1960
    Individual (1 offspring)
    Officer
    2016-09-08 ~ now
    OF - Director → CIF 0
  • 2
    Murphy, Michael James, Dr
    Portfolio Manager born in September 1976
    Individual (7 offsprings)
    Officer
    2023-07-04 ~ now
    OF - Director → CIF 0
  • 3
    Timmins, Vrede-sherden Felicitas
    Director born in September 1981
    Individual (4 offsprings)
    Officer
    2015-12-07 ~ now
    OF - Director → CIF 0
  • 4
    Clark, Andrew Thomas, Dr
    Doctor born in May 1965
    Individual (1 offspring)
    Officer
    2017-10-13 ~ now
    OF - Director → CIF 0
  • 5
    Ewan, Pamela Wilson, Dr
    Doctor born in September 1945
    Individual (1 offspring)
    Officer
    2017-10-13 ~ now
    OF - Director → CIF 0
  • 6
    Phillips Iii, Baxter Francis
    Chief Executive born in May 1975
    Individual (1 offspring)
    Officer
    2018-10-25 ~ now
    OF - Director → CIF 0
  • 7
    Murdoch, Stephen Iain
    Director born in January 1968
    Individual (5 offsprings)
    Officer
    2024-01-19 ~ now
    OF - Director → CIF 0
Ceased 4
  • 1
    Murphy, Michael James, Dr
    Portfolio Manager born in September 1976
    Individual (7 offsprings)
    Officer
    2021-11-17 ~ 2023-05-08
    OF - Director → CIF 0
  • 2
    Ewan, Pamela Wilson, Dr
    Allergy Consultant born in September 1945
    Individual (1 offspring)
    Officer
    2016-07-18 ~ 2016-09-08
    OF - Director → CIF 0
  • 3
    Milner, Jonathan Simon, Dr
    Director born in May 1965
    Individual (16 offsprings)
    Officer
    2016-06-06 ~ 2023-05-08
    OF - Director → CIF 0
    Dr Jonathan Simon Milner
    Born in May 1965
    Individual (16 offsprings)
    Person with significant control
    2016-06-06 ~ 2023-07-04
    PE - Has significant influence or controlCIF 0
  • 4
    Addenbrooke's Hospital, Hills Road, Cambridge, United Kingdom
    Corporate (2 offsprings)
    Person with significant control
    2020-03-19 ~ 2020-03-19
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

CAMBRIDGE ALLERGY LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
203,704 GBP2022-12-31
225,926 GBP2021-12-31
Property, Plant & Equipment
268,594 GBP2022-12-31
461,829 GBP2021-12-31
Fixed Assets - Investments
39,312 GBP2022-12-31
39,312 GBP2021-12-31
Fixed Assets
511,610 GBP2022-12-31
727,067 GBP2021-12-31
Debtors
189,228 GBP2022-12-31
612,814 GBP2021-12-31
Cash at bank and in hand
428,794 GBP2022-12-31
176,849 GBP2021-12-31
Current Assets
618,022 GBP2022-12-31
789,663 GBP2021-12-31
Creditors
Amounts falling due within one year
-1,933,764 GBP2022-12-31
-241,005 GBP2021-12-31
Net Current Assets/Liabilities
-1,315,742 GBP2022-12-31
548,658 GBP2021-12-31
Total Assets Less Current Liabilities
-804,132 GBP2022-12-31
1,275,725 GBP2021-12-31
Creditors
Amounts falling due after one year
0 GBP2022-12-31
-1,519,984 GBP2021-12-31
Net Assets/Liabilities
-804,132 GBP2022-12-31
-244,259 GBP2021-12-31
Equity
Called up share capital
215 GBP2022-12-31
208 GBP2021-12-31
Share premium
5,112,229 GBP2022-12-31
4,545,463 GBP2021-12-31
Retained earnings (accumulated losses)
-6,418,166 GBP2022-12-31
-5,280,115 GBP2021-12-31
Equity
-804,132 GBP2022-12-31
-244,259 GBP2021-12-31
Average Number of Employees
112022-01-01 ~ 2022-12-31
102021-01-01 ~ 2021-12-31
Intangible Assets - Gross Cost
350,000 GBP2022-12-31
350,000 GBP2021-12-31
Intangible Assets - Accumulated Amortisation & Impairment
146,296 GBP2022-12-31
124,074 GBP2021-12-31
Intangible Assets - Increase From Amortisation Charge for Year
22,222 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
968,820 GBP2022-12-31
938,344 GBP2021-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
700,226 GBP2022-12-31
476,515 GBP2021-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
223,711 GBP2022-01-01 ~ 2022-12-31

Related profiles found in government register
  • CAMBRIDGE ALLERGY LTD
    Info
    Registered number 09905065
    Hoeford Point, Barwell Lane, Gosport, Hampshire PO13 0AU
    Private Limited Company incorporated on 2015-12-07 (9 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-12-06
    CIF 0
  • CAMBRIDGE ALLERGY LTD
    S
    Registered number 9905065
    Ideaspace Bay 13, Cambridge Biomedical Campus, Hills Road, Cambridge, United Kingdom, CB2 0SP
    Company Limited By Shares in Register Of Companies For England And Wales, England And Wales
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • Beech House, 4a Newmarket Road, Cambridge, England
    Dissolved Corporate (2 parents)
    Person with significant control
    2016-06-06 ~ dissolved
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
    CIF 1 - Right to appoint or remove directorsOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.